Skip to main content
Caplight Logo









Kalohexis

Kalohexis

Private
Northbrook, IllinoisHealthcare & Life Scienceshttps://www.kalohexis.com/

Company Overview

Kalohexis is a clinical-stage biotechnology company that develops treatments for metabolic disorders such as obesity and cancer cachexia by harnessing the melanocortin system.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

peptide therapeuticsobesity treatmentMC3R/MC4R agonistoral obesity drugcancer cachexiaclinical-stage biotechmelanocortin systemdurable weight lossGLP-1 alternativeweight loss drugsmetabolic set-pointanti-obesity medicationMC3R/MC4R antagonistmetabolic disorderslean muscle massdrug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kalohexis Comparables

Compare Kalohexis with similar companies based on industry and business-model similarity.

Kalohexis comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Endevica Bio
85%
Courage Therapeutics
82%
Kailera Therapeutics
68%

Kalohexis Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Kalohexis Filings

Explore SEC and related filing metadata, where available.

Kalohexis filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Kalohexis's valuation, stock price, and market status.

Is Kalohexis a public or private company?

Kalohexis is a private company.

What is the current stock price of Kalohexis?

Kalohexis is a private company with no public stock price. No recent secondary market data is available.

How much is Kalohexis worth (valuation)?

Valuation information for Kalohexis is not publicly available.

Can I buy Kalohexis stock?

Kalohexis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Kalohexis's last funding round?

Funding round information for Kalohexis is not publicly available.

Who are the main investors in Kalohexis?

Investor information for Kalohexis is not publicly disclosed.

Will Kalohexis IPO soon?

No public IPO plans have been announced for Kalohexis.

How can I track Kalohexis secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Kalohexis's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNorthbrook, Illinois
Year Founded2026
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?